Skip to Main Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know:

Get the latest public health information from CDC:

Get the latest research information from NIH:

Here you can browse the complete list of publications for studies listed on CDAS.

Publication Year
Title PubMed Id Authors Journal Abbreviation Year Studies
A web server for inferring the human N-acetyltransferase-2 (NAT2) enzymatic phenotype from NAT2 genotype. 19261719 Kuznetsov IB, McDuffie M, Moslehi R Bioinformatics 2009 PLCO
Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility. 19383797 Lou H, Yeager M, Li H, Bosquet JG, Hayes RB, Orr N, Yu K, Hutchinson A, Jacobs KB, Kraft P, Wacholder S, Chatterjee N, Feigelson HS, Thun MJ, Diver WR, Albanes D, Virtamo J, Weinstein S, Ma J, Gaziano JM, Stampfer M, Schumacher FR, Giovannucci E, Ca… Proc. Natl. Acad. Sci. U.S.A. 2009 PLCO
A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. 19836008 Landi MT, Chatterjee N, Yu K, Goldin LR, Goldstein AM, Rotunno M, Mirabello L, Jacobs K, Wheeler W, Yeager M, Bergen AW, Li Q, Consonni D, Pesatori AC, Wacholder S, Thun M, Diver R, Oken M, Virtamo J, Albanes D, Wang Z, Burdette L, Doheny KF, Pugh E… Am. J. Hum. Genet. 2009 PLCO
Fine-mapping and family-based association analyses of prostate cancer risk variants at Xp11. 19549809 Lu L, Sun J, Isaacs SD, Wiley KE, Smith S, Pruett K, Zhu Y, Zhang Z, Wiklund F, Grönberg H, Walsh PC, Chang BL, Zheng SL, Isaacs WB, Xu J Cancer Epidemiol. Biomarkers Prev. 2009 PLCO
Cumulative incidence of false-positive results in repeated, multimodal cancer screening. 19433838 Croswell JM, Kramer BS, Kreimer AR, Prorok PC, Xu JL, Baker SG, Fagerstrom R, Riley TL, Clapp JD, Berg CD, Gohagan JK, Andriole GL, Chia D, Church TR, Crawford ED, Fouad MN, Gelmann EP, Lamerato L, Reding DJ, Schoen RE Ann Fam Med 2009 PLCO
The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer. 19493248 Mirabello L, Huang WY, Wong JY, Chatterjee N, Reding D, Crawford ED, De Vivo I, Hayes RB, Savage SA Aging Cell 2009 PLCO
Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. 19179464 Landgren O, Kyle RA, Pfeiffer RM, Katzmann JA, Caporaso NE, Hayes RB, Dispenzieri A, Kumar S, Clark RJ, Baris D, Hoover R, Rajkumar SV Blood 2009 PLCO
Two independent prostate cancer risk-associated Loci at 11q13. 19505914 Zheng SL, Stevens VL, Wiklund F, Isaacs SD, Sun J, Smith S, Pruett K, Wiley KE, Kim ST, Zhu Y, Zhang Z, Hsu FC, Turner AR, Johansson JE, Liu W, Kim JW, Chang BL, Duggan D, Carpten J, Rodriguez C, Isaacs W, Grönberg H, Xu J Cancer Epidemiol. Biomarkers Prev. 2009 PLCO
Effect of obesity at age 20 and 50 on development of prostate cancer in the PLCO Cancer Screening trial. Grubb RL, Black A, Church TR, Hickey T, Izmirlian G, Riley T, Prorok PC, Berg CD, Crawford ED, Andriole GL J Urol 2009 PLCO
Serum retinol and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial. 19336558 Schenk JM, Riboli E, Chatterjee N, Leitzmann MF, Ahn J, Albanes D, Reding DJ, Wang Y, Friesen MD, Hayes RB, Peters U Cancer Epidemiol. Biomarkers Prev. 2009 PLCO
Comprehensive resequence analysis of a 97 kb region of chromosome 10q11.2 containing the MSMB gene associated with prostate cancer. 19644707 Yeager M, Deng Z, Boland J, Matthews C, Bacior J, Lonsberry V, Hutchinson A, Burdett LA, Qi L, Jacobs KB, Gonzalez-Bosquet J, Berndt SI, Hayes RB, Hoover RN, Thomas G, Hunter DJ, Dean M, Chanock SJ Hum. Genet. 2009 PLCO
Results from four rounds of ovarian cancer screening in a randomized trial. 19305319 Partridge E, Kreimer AR, Greenlee RT, Williams C, Xu JL, Church TR, Kessel B, Johnson CC, Weissfeld JL, Isaacs C, Andriole GL, Ogden S, Ragard LR, Buys SS, PLCO Project Team Obstet Gynecol 2009 PLCO
SLC6A3 and body mass index in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. 19183461 Azzato EM, Morton LM, Bergen AW, Wang SS, Chatterjee N, Kvale P, Yeager M, Hayes RB, Chanock SJ, Caporaso NE BMC Med. Genet. 2009 PLCO
CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium. 19789370 Travis RC, Schumacher F, Hirschhorn JN, Kraft P, Allen NE, Albanes D, Berglund G, Berndt SI, Boeing H, Bueno-de-Mesquita HB, Calle EE, Chanock S, Dunning AM, Hayes R, Feigelson HS, Gaziano JM, Giovannucci E, Haiman CA, Henderson BE, Kaaks R, Kolonel… Cancer Epidemiol. Biomarkers Prev. 2009 PLCO
Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3). 19574343 Ahn J, Schumacher FR, Berndt SI, Pfeiffer R, Albanes D, Andriole GL, Ardanaz E, Boeing H, Bueno-de-Mesquita B, Chanock SJ, Clavel-Chapelon F, Diver WR, Feigelson HS, Gaziano JM, Giovannucci E, Haiman CA, Henderson BE, Hoover RN, Kolonel LN, Kraft P,… Hum. Mol. Genet. 2009 PLCO
Pre-biopsy prostate cancer nomograms based upon serial PSA screening data in the PLCO trial with verfication bias correction. Izmirlian G, Grubb RL, Black A, Prorok PC, Berg CD, Crawford ED, Andriole GL, Kibel AS J Urol 2009 PLCO
Collecting 48,000 CT exams for the lung screening study of the National Lung Screening Trial. 18777192 Clark KW, Gierada DS, Marquez G, Moore SM, Maffitt DR, Moulton JD, Wolfsberger MA, Koppel P, Phillips SR, Prior FW J Digit Imaging 2009 NLST
The yield of surveillance colonoscopy by adenoma history and time to examination. 18829395 Pinsky PF, Schoen RE, Weissfeld JL, Church T, Yokochi LA, Doria-Rose VP, Prorok P Clin. Gastroenterol. Hepatol. 2009 PLCO
Prediction of true positive lung cancers in individuals with abnormal suspicious chest radiographs: a prostate, lung, colorectal, and ovarian cancer screening trial study. 19404219 Tammemagi MC, Freedman MT, Pinsky PF, Oken MM, Hu P, Riley TL, Ragard LR, Berg CD, Prorok PC J Thorac Oncol 2009 PLCO
A prospective study of serum soluble CD30 concentration and risk of non-Hodgkin lymphoma. 19638620 Purdue MP, Lan Q, Martinez-Maza O, Oken MM, Hocking W, Huang WY, Baris D, Conde B, Rothman N Blood 2009 PLCO